Publications

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model

 73
Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model

Tags:

Previous Article

How muscle cells grow and stay healthy

Next Article

MicroRNA-based gene therapy to treat ALS 

Related Posts

Microbes, molecules, and the maternal–fetal interface: rethinking the gut–placenta axis

Microbes, molecules, and the maternal–fetal interface: ...

 137

MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression in mice

MALT1 protease inhibition restrains glioblastoma progre...

 76

Nondigestible stachyose binds membranous HSP90b on small intestinal epithelium to regulate the exosomal miRNAs: A new function and mechanism

Nondigestible stachyose binds membranous HSP90b on smal...

 100